Pro-Dex Q1 Sales Up 11% to $20.6M, Gross Margin 33%; Net Income Falls on Prior-Year Investment Gain
PDEX has more than doubled off its 52-week low of $28.578.
Summary
Pro-Dex opened fiscal 2027 with $20.6M in sales (up 11%) and 33% gross margin, but net income fell to $3.0M from $4.7M on a prior-year investment gain. Backlog stands at $43.1M, and three insiders adopted new 10b5-1 selling plans.
Key Events · Earnings and Guidance · PDEX
-
Q1 Sales Up 11% to $20.6M
Net sales rose to $20,560 thousand from $18,530 thousand, led by medical device sales up 21% to $17.4M; repair revenue fell 44% to $2.1M.
-
Gross Margin Expands to 33%
Gross profit rose 28% to $6,857 thousand from $5,367 thousand, with margin up four points to 33% on favorable product mix.
-
Net Income Falls to $3.0M
Net income was $3,048 thousand ($0.95 basic, $0.92 diluted) versus $4,680 thousand ($1.43, $1.40), as the prior year included a $3,299 thousand unrealized investment gain.
-
Backlog $43.1M for Fiscal 2027
Firm purchase orders totaled approximately $43.1 million at September 30, 2026, with $42.4 million scheduled for delivery during the remainder of fiscal 2027.
Analysis · PDEX · Industrial Applications And Services
Sales grew 11% and gross margin expanded four points to 33%, but net income dropped to $3.0M from $4.7M because last year's quarter included a $3.3M unrealized investment gain that did not repeat. Backlog of $43.1M, with $42.4M due this fiscal year, gives unusually strong revenue visibility for a company this size. The offsetting risks are concentration (one customer is 72% of sales) and a supplier delay that could push next-generation handpiece shipments behind schedule. Separately, three insiders — the chairman, a director, and the CEO — adopted 10b5-1 selling plans covering up to $5.0M, 150,000 shares, and 20,000 shares respectively, which adds a future supply overhang.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PDEX was trading at $61.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $199.2M. The 52-week trading range was $28.58 to $77.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.